adplus-dvertising
Connect with us

News

How a failed deal with China to produce a made-in-Canada COVID-19 vaccine wasted months and millions – CBC.ca

Published

 on


The federal government’s failed collaboration with a vaccine manufacturing company in China early in the pandemic has led to a delay of nearly two years in efforts to create a made-in-Canada COVID-19 vaccine.

Government documents obtained by The Fifth Estate show that Canadian officials wasted months waiting for a proposed vaccine to arrive from China for further testing and spent millions upgrading a production facility that never made a single dose of COVID-19 vaccine. 

The National Research Council of Canada (NRC) signed an agreement with Tianjin-based CanSino Biologics in early May 2020 to “fast-track the availability of a COVID-19 vaccine in Canada for emergency pandemic use.”

The CanSino vaccine, which had been created by the scientific research arm of China’s military, was to be shipped to Canada for human trials that May. If successful, the vaccine was to be manufactured at a temporary facility in Montreal that the NRC had committed $44 million to upgrade.

  • WATCH: The Fifth Estate | The Vaccine: What went wrong? on CBC-TV and CBC Gem Thursday at 9 p.m.

The documents reveal that the NRC, the scientific research arm of the Canadian government, was gearing up for production of the vaccine — even before the contract was signed and human trials had started — estimating it could be manufacturing doses by summer 2020.

At first, the NRC would be producing doses for human trials in Canada, then later, according to the contract, “for front-line responders and Canadians as soon as they are available.”

The CanSino-Canada deal was originally hoped to quickly provide vaccines for emergency use by front-line responders. (Leah Hennel/Alberta Health Services)

“Once fully operational, in the event that CanSino proceeds, NRC will be able to produce 70,000 to 100,000 doses per month,” the NRC briefs said.

The NRC asked Dr. Scott Halperin, director of the Canadian Center of Vaccinology in Halifax, to design the clinical trials for CanSino in Canada.

“The NRC and CanSino had previous collaborations well before the pandemic,” Halperin said in an interview with The Fifth Estate. “That was leveraged into a working relationship to say: ‘Can that be expanded for the current crisis?’ “

Vaccine stuck in China

As the months progressed, the documents also show that the NRC was working to increase the number of doses the facility could produce for the public.

But ultimately, the CanSino vaccine would never get to Canada.

Prime Minister Justin Trudeau announced the deal to Canadians on May 16, 2020. But a federal government memo later that same month reveals the Canadian Embassy in Beijing was still working to get the vaccine cleared by China’s customs.

“CanSino vaccines are still with customs in China,” the memo said. “Embassy has a [meeting] tomorrow. Assuming they get through customs [tomorrow], they can be put on a flight on the 27th.”

But the vaccine candidate was not put on a plane on May 27.

That same day, Huawei CFO Meng Wanzhou — a high-profile tech executive in China — lost an appeal to the B.C. Supreme Court arguing against her arrest in Canada. Meng had been detained in Vancouver in 2018 on U.S. bank fraud charges.

(Meng was returned to China last month after signing a deferred prosecution agreement with the U.S. Attorney General’s Office. Shortly after, two Canadians held in prisons in China were allowed to return to Canada.)

Huawei CFO Meng Wanzhou waves as she steps out of an airplane after arriving at Shenzhen Bao’an International Airport in Shenzhen in southern China’s Guangdong province on Sept. 25, 2021. Meng signed a deferred prosecution agreement with U.S. prosecutors that allowed her to leave Canada for the first time in nearly three years. (Jin Liwang/Xinhua via The Associated Press)

“I was incredulous that the government had chosen to partner with not only CanSino, but with China, after all the things that had happened,” Conservative MP Michael Chong said.

Chong has served as the party’s foreign affairs critic and on the parliamentary committee on Canada-China relations. 

“It was clear by May of 2020 that China was not a reliable partner,” he said.

Michael Chong, a former Conservative foreign affairs critic, has been outspoken regarding national security issues and China’s human rights record. (Joe Fiorino/CBC)

On June 19, 2020, only weeks after Meng lost her court appeal, China accused Canadians Michael Kovrig and Michael Spavor of espionage. They had already been held in Chinese prisons without charges for more than 500 days.

A war of words ensued between the governments in China and Canada, with officials from each country criticizing the other.

WATCH | McGill professor says connection to China’s army risky:

Security professor doubts customs stopped the vaccine

16 hours ago

Ben Fung, a security researcher with McGill University, tells The Fifth Estate’s Bob McKeown that a partnership with a company closely tied to China’s military would be risky. 0:59

By June 26, NRC bureaucrats acknowledged in briefs that the “shipment of vaccine material has stalled.” 

By early July, the CanSino candidate was still the only vaccine Health Canada had approved for human trials in Canada. NRC officials continued to hope it would arrive later that month.

“CanSino remains very committed to the Canadian clinical trials,” the brief said.

Into August, NRC documents reveal, officials continued working on manufacturing plans, despite the fact that the vaccine candidate had “not yet been approved by Chinese customs for shipment to Canada.”

Customs not the problem

Ben Fung, a security researcher at McGill University in Montreal and an outspoken China critic, said he doubts that customs was the issue, and argued that Canada should have known partnering with CanSino was risky because of the company’s connection to both China’s military and government. 

“So when they say customs is stopping the vaccines, of course this is not the case,” Fung said. “The [Chinese Communist Party] is upper management.”

WATCH | The original plans for the CanSino-Canada vaccine:

The CanSino-Canada vaccine plan

16 hours ago

The Fifth Estate’s Bob McKeown looks at the plans for a CanSino-Canada vaccine partnership by hearing from CanSino’s Canadian scientific adviser, Dr. Luis Barreto, who is a longtime vaccine specialist, and Dr. Scott Halperin, who was hired to run clinical trials for the company. 2:09

At the Center for Vaccinology, Halperin suspected that the project had become wrapped up in the diplomatic tensions between Canada and China. When he saw the vaccine had been shipped to Pakistan and Russia without issue, he knew the vaccine was not coming to Canada.

“Then we knew it wasn’t just the right paperwork and bureaucracy,” Halperin said. “It became clear that that wasn’t the case, but that took another month to two months to finally decide that no, it must be politics. It can’t be anything else.”

The Globe and Mail first reported on Aug. 25, 2020, that the NRC had abandoned its collaboration with CanSino because China wouldn’t let the vaccine doses come to Canada.

WATCH | CanSino’s CEO on why the vaccine didn’t come to Canada:

CanSino CEO on why the vaccine didn’t come to Canada

16 hours ago

Dr. Xuefeng Yu, co-founder of CanSino, says he had hoped to get the vaccine into Canada, the country where his family lives. He tells The Fifth Estate’s Bob McKeown how that unfolded. 1:19

In an interview with The Fifth Estate, CanSino CEO Dr. Xuefeng Yu said he did not know why the vaccine wasn’t allowed to be sent to Canada.

“I don’t work for the government, either side. I really have no clue what’s going on behind the doors of the department of … each country.”

Yu said that by the time the shipment was delayed into August, there was no point proceeding with trials in Canada. By then, CanSino was already in Phase 3 global trials elsewhere.

Millions of doses promised

Trudeau and Industry Minister Navdeep Bains held a media conference at the NRC on Aug. 31, 2020, touting the Montreal lab that had been upgraded to produce the CanSino vaccine.

Even though the federal government no longer had a vaccine partner, the Prime Minister’s Office announced that the facility would “enable the preliminary production of 250,000 doses of vaccine per month starting in November 2020.”

However, that facility did not produce 250,000 doses of vaccine in November 2020, or any month since. 

“One would hope that when the prime minister speaks, he knows what he’s talking about and it’s accurate,” NDP MP and health critic Don Davies said in an interview with The Fifth Estate.

“So he either was mistaken or he was misleading, and I think it’s incumbent on him to explain which of those it is. What we do know is that we didn’t produce 250,000 doses in Canada in November in Montreal.”

Don Davies was the NDP health critic when the CanSino vaccine deal was discussed at a parliamentary committee. (Ian Christie/CBC)

To this day, no vaccines have been produced at that NRC facility.

In August 2020, Trudeau also announced that a new NRC lab in Montreal would be producing two million doses a month by mid-2021.

That has also not happened. According to the NRC, vaccines will not be produced there until 2022, at the earliest.

Trudeau, right, alongside Minister for Economic Development Melanie Joly, left, and Minister of Innovation, Science and Industry Navdeep Bains arrive for a news conference and visit to the National Research Council of Canada Royalmount Human Health Therapeutics Research Centre on Aug. 31, 2020. (Graham Hughes/The Canadian Press)

The Prime Minister’s Office did not answer when asked to explain the discrepancy between the promised production numbers and what happened. The prime minister and his ministers also declined interview requests about Canada’s early vaccine production plans, including with the NRC and CanSino.

The NRC has said the U.S.-based vaccine developer Novavax will be its new partner for this facility, but Health Canada has not approved its vaccine yet.

The National Research Council of Canada is adding two manufacturing facilities for vaccines at its campus in Montreal. One will make vaccines for use in clinical trials and the other will produce vaccines for public use. (Vianney Leudiere/Radio-Canada)

The NRC declined interview requests with its officials but provided written responses to questions.

“It was deemed prudent to seize the opportunity to obtain access to CanSino’s vaccine candidate — one of the most advanced at the time,” the NRC said.

The NRC also acknowledged that the failure of the CanSino deal forced it to scrap its original clinical trial manufacturing plans. 

“I think there’s no doubt it has set us back years,” Davies said. “When you’re in a global pandemic, that is deadly, that costs lives.”

CanSino seizes Fifth Estate interview

Yu is proud of CanSino’s COVID-19 vaccine that’s going into millions of arms around the world.

The company CEO sat down with The Fifth Estate for a wide-ranging interview, discussing his roots in Canada’s pharmaceutical industry, his family who still lives in Toronto and his research work with China’s military.

“I see them as collaborators, it’s just a research institute, right?” Yu said.

CanSino Biologics Inc. is headquartered in Tianjin, China, an industrial city southeast of Beijing. The company has a large manufacturing facility and offices at the site. (Tribal Productions Asia)

But when the cameras turned off, he was clearly not happy with how the interview unfolded.

As the CBC freelance camera crew packed up their gear in the CanSino Biologics offices in Tianjin, China, company officials seized the interview recording.

CanSino deleted half of the recording before giving it back 10 days later. Luckily, The Fifth Estate recorded the entire interview from Toronto.

China officials may have denied the CanSino vaccine candidate to Canada, but Canadian scientists and labs are still supporting CanSino’s COVID-19 vaccine, which is being used in at least nine countries.

A health-care worker injects a teacher with a dose of the CanSino COVID-19 vaccine in Mexico City. CanSino’s vaccine has been approved for emergency pandemic use in a handful of countries worldwide. Phase 3 trials are ongoing. (Marco Ugarte/The Associated Press)

The Center for Vaccinology in Halifax continues to work for CanSino, with Halperin running the company’s Phase 3 global trials on a $3.5-million contract.

“That vaccine will likely never come to Canada at this stage. It’s going to be used around the world in other places, but not in Canada,” Halperin said. “I look at this as a part of Canada’s contribution to the global battle against COVID-19.”

  • If you have tips on this or any other story, please contact The Fifth Estate team.

Adblock test (Why?)

728x90x4

Source link

Continue Reading

News

Canada’s Denis Shapovalov wins Belgrade Open for his second ATP Tour title

Published

 on

BELGRADE, Serbia – Canada’s Denis Shapovalov is back in the winner’s circle.

The 25-year-old Shapovalov beat Serbia’s Hamad Medjedovic 6-4, 6-4 in the Belgrade Open final on Saturday.

It’s Shapovalov’s second ATP Tour title after winning the Stockholm Open in 2019. He is the first Canadian to win an ATP Tour-level title this season.

His last appearance in a tournament final was in Vienna in 2022.

Shapovalov missed the second half of last season due to injury and spent most of this year regaining his best level of play.

He came through qualifying in Belgrade and dropped just one set on his way to winning the trophy.

Shapovalov’s best results this season were at ATP 500 events in Washington and Basel, where he reached the quarterfinals.

Medjedovic was playing in his first-ever ATP Tour final.

The 21-year-old, who won the Next Gen ATP Finals presented by PIF title last year, ends 2024 holding a 9-8 tour-level record on the season.

This report by The Canadian Press was first published Nov. 9, 2024.

The Canadian Press. All rights reserved.



Source link

Continue Reading

News

Talks to resume in B.C. port dispute in bid to end multi-day lockout

Published

 on

VANCOUVER – Contract negotiations resume today in Vancouver in a labour dispute that has paralyzed container cargo shipping at British Columbia’s ports since Monday.

The BC Maritime Employers Association and International Longshore and Warehouse Union Local 514 are scheduled to meet for the next three days in mediated talks to try to break a deadlock in negotiations.

The union, which represents more than 700 longshore supervisors at ports, including Vancouver, Prince Rupert and Nanaimo, has been without a contract since March last year.

The latest talks come after employers locked out workers in response to what it said was “strike activity” by union members.

The start of the lockout was then followed by several days of no engagement between the two parties, prompting federal Labour Minister Steven MacKinnon to speak with leaders on both sides, asking them to restart talks.

MacKinnon had said that the talks were “progressing at an insufficient pace, indicating a concerning absence of urgency from the parties involved” — a sentiment echoed by several business groups across Canada.

In a joint letter, more than 100 organizations, including the Canadian Chamber of Commerce, Business Council of Canada and associations representing industries from automotive and fertilizer to retail and mining, urged the government to do whatever it takes to end the work stoppage.

“While we acknowledge efforts to continue with mediation, parties have not been able to come to a negotiated agreement,” the letter says. “So, the federal government must take decisive action, using every tool at its disposal to resolve this dispute and limit the damage caused by this disruption.

“We simply cannot afford to once again put Canadian businesses at risk, which in turn puts Canadian livelihoods at risk.”

In the meantime, the union says it has filed a complaint to the Canada Industrial Relations Board against the employers, alleging the association threatened to pull existing conditions out of the last contract in direct contact with its members.

“The BCMEA is trying to undermine the union by attempting to turn members against its democratically elected leadership and bargaining committee — despite the fact that the BCMEA knows full well we received a 96 per cent mandate to take job action if needed,” union president Frank Morena said in a statement.

The employers have responded by calling the complaint “another meritless claim,” adding the final offer to the union that includes a 19.2 per cent wage increase over a four-year term remains on the table.

“The final offer has been on the table for over a week and represents a fair and balanced proposal for employees, and if accepted would end this dispute,” the employers’ statement says. “The offer does not require any concessions from the union.”

The union says the offer does not address the key issue of staffing requirement at the terminals as the port introduces more automation to cargo loading and unloading, which could potentially require fewer workers to operate than older systems.

The Port of Vancouver is the largest in Canada and has seen a number of labour disruptions, including two instances involving the rail and grain storage sectors earlier this year.

A 13-day strike by another group of workers at the port last year resulted in the disruption of a significant amount of shipping and trade.

This report by The Canadian Press was first published Nov. 9, 2024.

The Canadian Press. All rights reserved.



Source link

Continue Reading

News

The Royal Canadian Legion turns to Amazon for annual poppy campaign boost

Published

 on

The Royal Canadian Legion says a new partnership with e-commerce giant Amazon is helping boost its veterans’ fund, and will hopefully expand its donor base in the digital world.

Since the Oct. 25 launch of its Amazon.ca storefront, the legion says it has received nearly 10,000 orders for poppies.

Online shoppers can order lapel poppies on Amazon in exchange for donations or buy items such as “We Remember” lawn signs, Remembrance Day pins and other accessories, with all proceeds going to the legion’s Poppy Trust Fund for Canadian veterans and their families.

Nujma Bond, the legion’s national spokesperson, said the organization sees this move as keeping up with modern purchasing habits.

“As the world around us evolves we have been looking at different ways to distribute poppies and to make it easier for people to access them,” she said in an interview.

“This is definitely a way to reach a wider number of Canadians of all ages. And certainly younger Canadians are much more active on the web, on social media in general, so we’re also engaging in that way.”

Al Plume, a member of a legion branch in Trenton, Ont., said the online store can also help with outreach to veterans who are far from home.

“For veterans that are overseas and are away, (or) can’t get to a store they can order them online, it’s Amazon.” Plume said.

Plume spent 35 years in the military with the Royal Engineers, and retired eight years ago. He said making sure veterans are looked after is his passion.

“I’ve seen the struggles that our veterans have had with Veterans Affairs … and that’s why I got involved, with making sure that the people get to them and help the veterans with their paperwork.”

But the message about the Amazon storefront didn’t appear to reach all of the legion’s locations, with volunteers at Branch 179 on Vancouver’s Commercial Drive saying they hadn’t heard about the online push.

Holly Paddon, the branch’s poppy campaign co-ordinator and bartender, said the Amazon partnership never came up in meetings with other legion volunteers and officials.

“I work at the legion, I work with the Vancouver poppy office and I go to the meetings for the Vancouver poppy campaign — which includes all the legions in Vancouver — and not once has this been mentioned,” she said.

Paddon said the initiative is a great idea, but she would like to have known more about it.

The legion also sells a larger collection of items at poppystore.ca.

This report by The Canadian Press was first published Nov. 9, 2024.

The Canadian Press. All rights reserved.



Source link

Continue Reading

Trending